HUTCHMED (China) Limited

HCM · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income$37,729$100,780-$360,386-$167,041
Dep. & Amort.$12,341$8,207$8,664$7,190
Deferred Tax$0-$102,757$0-$115,137
Stock-Based Comp.$21,609$36,600$30,586$41,990
Change in WC-$62,169$71,146$58,704$32,458
Other Non-Cash-$9,013$105,282-$6,167-$3,683
Operating Cash Flow$497$219,258-$268,599-$204,223
Investing Activities
PP&E Inv.-$17,933-$32,612-$36,664-$16,756
Net Acquisitions$0-$2,990$324$159,118
Inv. Purchases-$1,848,808-$1,627,875-$1,202,013-$1,370,976
Inv. Sales/Matur.$1,769,403$1,372,341$1,518,453$921,364
Other Inv. Act.$1,278$0$16,488$930
Investing Cash Flow-$96,060-$291,136$296,588-$306,320
Financing Activities
Debt Repay.$5,607$61,705-$9,170-$580
Stock Issued$790$5,094$174$717,319
Stock Repurch.-$36,064-$9,071-$48,084-$27,309
Dividends Paid$0$0-$87,436-$99,744
Other Fin. Act.-$1,000-$9,068$61,753$60,342
Financing Cash Flow-$30,667$48,660-$82,763$650,028
Forex Effect-$3,401-$6,471-$9,490$2,427
Net Chg. in Cash-$129,631-$29,689-$64,264$141,912
Supplemental Information
Beg. Cash$283,589$313,278$377,542$235,630
End Cash$153,958$283,589$313,278$377,542
Free Cash Flow-$17,436$186,646-$305,263-$220,979